5 news items
Vivani Medical to Present at TIDES Conference 2024
VANI
9 May 24
Medical develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
VANI
26 Mar 24
with the requested NPM-119 Chemistry, Manufacturing and Controls information in the first half of this year, with the goal of obtaining an Investigational New
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
VANI
6 Mar 24
develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
VANI
1 Mar 24
designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve
Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio
VANI
28 Feb 24
to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve medication tolerability
- Prev
- 1
- Next